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Despite global efforts to reduce preventable 
maternal and neonatal mortality, Nigeria’s 
maternal mortality ratio is estimated at 576 
deaths per 100,000 live births and neonatal 
death is estimated at 37 per 1,000 live 
births 1.
Maternal and newborn deaths due to pre-eclampsia and 
eclampsia (PE/E) are preventable, yet in Nigeria this is the most 
significant direct cause of maternal mortality. 
Population Council conducted a landscape analysis on PE/E in 
2015 in seven states in Nigeria (Bauchi, Cross River, Ebonyi, 
Katsina, Kogi, Ondo, Sokoto). The main objectives of the 
landscape analysis were: 
• To understand the level of programmatic and policy 
support for PE/E prevention and treatment;
• To analyze the gaps in providers’ knowledge and 
competence in preventing, detecting, and managing PE/E;
• To determine primary health care (PHC) facilities’ 
capacities to manage PE/E;
• To assess community awareness, beliefs, and experiences 
around PE/E;
• To understand the volume of research on PE/E in the last 
15 years; and
• To determine priority areas for research and programmatic 
interventions around PE/E.
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PE/E IN BRIEF
• Pre-eclampsia is a condition               
in pregnant women marked by an 
increase in blood pressure and 
protein in urine after 20 weeks 
gestation.
• Providing high quality antenatal care 
improves the prevention and early 
detection of pre-eclampsia and can 
prevent its progression to eclampsia.
• Eclampsia is a life-threatening 
condition characterized by 
convulsions in women with PE.
• Women in developing countries are 
300 times more likely to die from 
eclampsia than women in developed 
countries.
• Pre-eclampsia and eclampsia can 
be managed by administering anti-
hypertensive drugs and magnesium 
sulphate (MgSO4).
• MgSO4 is the safest and most 
effective treatment for severe pre-
eclampsia and eclampsia, and is one 
of the 13 UN Life-Saving Commodities 
for Women and Children. 
• PE/E and other hypertensive 
disorders in pregnancy increase the 
risk of pre-term births, which can 
lead to low birth weight, anemia, and 
stunting.
• Improved prevention, increased 
detection, and effective treatment 
of PE/E can prevent unnecessary 
maternal and newborn deaths.
The Ending Eclampsia project seeks to expand access                
to proven, underutilized interventions and commodities             
for the prevention, early detection, and treatment of pre-
eclampsia and eclampsia and strengthen global partnerships.
Made possible by the generous support of the 
American people through the United States Agency for 
International Development (USAID).
2FIGURE 1    Proportion of facilities with key 
equipment to detect PE and manage severe PE/E
NATIONAL POLICY 
AWARENESS
Policymakers appear to understand the enormous 
burden of PE/E and its consequences for maternal and 
newborn survival. Though a majority of stakeholders 
interviewed understood the importance of antenatal 
care (ANC) for early detection of PE/E, few were 
aware of national guidelines on the diagnosis and 
management of PE/E. 
“Studies have shown MgSO4 is 
the best option [...] but I have not 
seen a national protocol written as 
such.” 
—POLICYMAKER, ONDO STATE
FACILITY CAPACITY AND 
PREPAREDNESS
To assess institutional preparedness, researchers 
visited 96 facilities in seven states in Nigeria and 
recorded that only 17% of the facilities had guidelines 
available for management of pre-eclampsia, 31% had 
all ANC equipment for detecting PE/E and 34% use 
MgSO4 for treating eclampsia. 
During these facility assessments, researchers 
determined whether the facilities had the key ANC 
equipment required to detect pre-eclampsia, manage 
severe PE/E, and monitor for MgSO4 toxicity (figure 1).
When asked, 42% of facility managers reported always 
using MgSO4 to treat PE/E, 20% said it is sometimes 
used, and 39% reported that it is never used. When 
asked how they obtain MgSO4, 36% of managers said 
they receive it routinely from central supply, 17% said 
the facility purchases it from the market, 39% ask 
clients to purchase it, and 9% said they procure it 
elsewhere (such as NGOs).
FIGURE 2    Provider knowledge of drugs for PE/E 
prevention and management (n=379)
“The drugs are not always in 
stock. It is not available the way 
it supposed to be; we have not 
attained the ideal situation yet. ” 
—ASST. DIRECTOR MEDICAL SERVICES, 
CROSS RIVER STATE
Hospitals have the capacity to perform most 
components of emergency obstetric and neonatal care 
(EmONC), but the landscape analysis showed limited 
capacity at PHCs for conducting even basic EmONC.
PROVIDER KNOWLEDGE AND 
SKILLS
Providers had good knowledge on signs and symptoms 
of PE (64%) and eclampsia (81%), but only 48.5% 
could correctly identify signs and symptoms of chronic 
hypertension and 9% could identify severe PE correctly. 
Researchers also assessed health providers’ 
knowledge related to drugs used for preventing and 
managing PE/E, as well as calcium gluconate to treat 
MgSO4 toxicity (figure 2).
Figure 2 shows limited provider knowledge on 
prophylactic use of calcium and aspirin for women 
at risk of PE and which anti-hypertensives (aldomet 
or nifedipine) to use for managing high BP during 
pregnancy. The Pritchard regimen for MgSO4 
administration is considered the ‘gold standard’ for 
preventing and treating convulsions in severe PE/E, 
but few providers (12%) could accurately describe the 
appropriate doses of MgSO4 or name calcium gluconate 
as the antidote for MgSO4 toxicity (7%). 
3FIGURE 3    Percent of clients who received all 
eight ANC components
men also said that to prevent these complications, they 
should encourage their wives to register early in their 
pregnancies for ANC, help them with house chores, turn 
to prayer, eat a balanced diet, notify health workers, 
give them support so they don’t ‘over think,’ and make 
them happy all the time. 
Women stated that high BP during pregnancy is caused 
by ‘over thinking’, shocking events, maltreatment from 
husbands, and poor diet. When a woman has high BP, 
communities blame witchcraft, unrest in the household, 
or an attack from family. Women’s solutions to prevent 
these complications included seeking spiritual or 
traditional help from imams and herbalists before 
going to a hospital and using vegetables, fresh eggs, 
cocoa seeds, and aloe vera. 
“If you have hypertension, 
the herbalist will tell you 
to do things, but where 
there is no money to do it, 
the high BP will continue. 
If you go to pray, prayer can help 
a little, but it can’t finish 
the high BP. High BP 
is the worst sickness in our town.” 
—FEMALE FGD PARTICIPANT, KOGI STATE
“They will put charcoal into the pot 
with other medicine and a child will 
be placed in between, believing this 
will cool the sickness.” 
—FEMALE FGD PARTICIPANT, EBONYI STATE
Overall, the qualitative findings show that the signs and 
symptoms associated with PE/E are often attributed 
to other causes and community members often 
seek traditional or spiritual healing before medical 
care. Misconceptions, myths, and mistrust between 
communities and health providers negatively influence 
care-seeking behaviors.
SURVIVORS’ EXPERIENCES
Interviews with survivors documented their care-
seeking pathways, including their PE/E experience, 
availability and accessibility of essential services and 
commodities, and the outcomes of the pregnancy 
QUALITY OF CARE
Quality of care was assessed through observations 
of 136 client-provider interactions and 136 client 
exit interviews with the same pregnant women. 
Researchers assessed eight essential components of 
quality ANC. Figure 3 describes the components the 
clients received during observations.
In addition to the eight essential components of ANC 
described above, there are specific questions and 
tests that help to assess a woman’s risk of developing 
PE/E, to detect PE/E, and inform clients of the signs of 
impending eclampsia. 
During 15% of the observed ANC consultations, 
providers performed the necessary checks to detect 
women at risk of developing PE: history of high blood 
pressure (BP) and diabetes; date of last delivery; client’s 
parity, age, weight, and edema of face, hands, legs, 
and ankles. Fifty-three percent of providers observed 
measured women’s BP and checked urine for protein. 
Eleven percent of the providers, however, advised 
the clients on the symptoms of impending eclampsia 
(severe headache, blurred vision, and pre-eclampsia 
with generalized body swelling).
COMMUNITY KNOWLEDGE 
AND PERCEPTIONS
The study included in-depth interviews (IDIs) and 
focus group discussions (FGDs) with PE/E survivors, 
community stakeholders, and families affected by 
PE/E. 
Married men reported witchcraft, economic problems, 
fear, spiritual attacks, self-medication, drinking alcohol, 
death of a loved one, and ‘over thinking’ as causes of 
high BP, swelling, and bleeding during pregnancy. The 
for mother and child. Survivors’ experiences provide 
insights that inform strategies to work more closely 
with communities and health facilities, and as a result, 
improve access to, and use of, quality care. 
The women interviewed were similar in age, ages at 
marriage and first pregnancy, and education. The 
following quotation demonstrates lack of awareness 
and poor health seeking behavior in a young woman 
during her first pregnancy.
“I lost the baby. It took a while 
before my blood pressure 
eventually normalized. 
The same headache was 
there, discomfort, and 
swelling of the legs was there 
for quite a long time 
after the baby died.” 
—PE/E SURVIVOR, CROSS RIVER STATE
DISCUSSION & CONCLUSION
This landscape analysis identified the gaps in facilities’ 
and providers’ capacities for preventing, detecting, and 
managing PE/E. It assessed community awareness, 
beliefs, and experiences of PE/E, and determined the 
gaps and priority areas for research and programs to 
improve access to prevention and treatment. 
It is clear, at the state policy level, that there is limited 
knowledge of what has been developed nationally, 
there is confusion about how policies, guidelines, and 
protocols reach primary health care facilities.
For effective PE/E management, health facilities 
need to stock necessary drugs and ANC equipment, 
and institutionalize guidelines for PE/E treatment. 
Researchers noted irregular supply of basic drugs, 
equipment, and supplies, particularly MgSO4, patella 
hammers and, calcium gluconate, which no facilities 
stocked. 
Providers’ knowledge is generally poor. Health care 
providers need to be trained and re-trained on PE 
prevention—including when to administer prophylactic 
drugs such as calcium supplements and aspirin—and 
early detection, and treatment using anti-hypertensives 
and MgSO4.
In addition to ensuring providers are adequately 
trained to administer MgSO4 at the right time, and with 
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the proper doses, they also need to know the warning 
signs for MgSO4 toxicity and how to treat it with calcium 
gluconate, if necessary. There is also limited capacity 
for newborn resuscitation.
The final, essential component to reduce mortality from 
PE/E is community awareness. Community members 
need to know the signs of PE/E and understand the 
danger it poses for mothers and babies so they can 
seek medical care promptly.
A multi-pronged approach is required to address the 
systematic issues that create barriers to women’s 
access to health care during pregnancy. Detecting and 
managing PE/E early can reduce preventable maternal 
and neonatal deaths in Nigeria.
RECOMMENDATIONS
• Advocacy for streamlining state procurement and 
link to a national or central distribution system;
• Connecting with United Nations Commission on 
Life-Saving Commodities (UNCoLSC) for Women 
and Children, especially for maternal drugs which 
include MgSO4;
• Training on quality ANC; 
• Introduce a task-shifting policy focusing on MNH 
“policy implementation plan” that includes anti-
hypertensives and MgSO4;
• Train PHC workers to detect and provide loading 
dose of MgSO4;
• Community awareness campaigns on the 
importance of ANC and seeking care early; and
• Engage men to encourage their support of their 
wives.
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